Ligand Pharmaceuticals Incorporated logo

Ligand Pharmaceuticals Incorporated

NASDAQ:LGND

Overview | Financials
Company Name Ligand Pharmaceuticals Incorporated
Symbol LGND
Currency USD
Price 99.41
Market Cap 1,785,771,417
Dividend Yield 0%
52-week-range 49.24 - 100.69
Industry Biotechnology
Sector Healthcare
CEO Mr. Todd C. Davis Ph.D.
Website https://www.ligand.com

An error occurred while fetching data.

About Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19; Teriparatide injection product for osteoporosis;

Related Stocks

Addus HomeCare Corporation logo

Addus HomeCare Corporation

ADUS

120.9 USD

Establishment Labs Holdings Inc. logo

Establishment Labs Holdings Inc.

ESTA

44.89 USD

ImmunityBio, Inc. logo

ImmunityBio, Inc.

IBRX

6.62 USD

Krystal Biotech, Inc. logo

Krystal Biotech, Inc.

KRYS

203.13 USD

Travere Therapeutics, Inc. logo

Travere Therapeutics, Inc.

TVTX

9.8 USD

Xenon Pharmaceuticals Inc. logo

Xenon Pharmaceuticals Inc.

XENE

42.92 USD

ModivCare Inc. logo

ModivCare Inc.

MODV

25.41 USD

Dynavax Technologies Corporation logo

Dynavax Technologies Corporation

DVAX

10.75 USD

Financials

Numbers are in millions USD

Numbers are in millions USD